Albuquerque, USA and Eindhoven, The Netherlands – April 17th, 2023 – Xyall and Indica Labs have entered into a global strategic partnership designed to bridge the gap between histology and molecular pathology. It unites Xyall’s unique automated tissue dissection solutions with Indica Labs’ AI-powered, diagnostic digital pathology platform.
4 May 2023 | Indica Labs is pleased to announce our Boston HALO® User Group Meeting at Le Méridien Boston Cambridge on May 4 from 1 pm – 6 pm.
11 April 2023 | Learn how to select an image management platform from Indica Labs and learn about available deployment and integration options .
In this blog post, you can learn about the latest release of HALO AP®, a CE marked, AI powered and pathologist driven image management platform from Indica Labs. We’ll discuss the new features in HALO AP 2.1, where to find training resources and documentation, and how the upgrade will be rolled out.
HALO AP® 2.1 Features and Functionalities Read More »
2 March 2023 | Learn about transformational change in how pathology services are delivered at Nottingham University Hospitals
Albuquerque, NM and Hamamatsu City, Japan, – 14th October 2022 – Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and Hamamatsu Photonics K.K., a forerunner in whole slide imaging systems, announced an agreement to maintain long-term interoperability between Indica Labs’ HALO AP® software platform and Hamamatsu’s NanoZoomer family of high-speed, high-resolution scanners.
Vista, CA – Sep 4, 2022, Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Indica Labs, the industry-leading provider of computational and image management software in digital pathology, today announced a partnership focused on delivering compatible digital pathology workflow solutions.
Albuquerque, NM, and Glasgow, Scotland, – 30 August, 2022 – Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD), announced today an agreement to collaborate on the development of an AI-based digital pathology solution for the detection of cancer within lymph nodes from colorectal surgery cases.
Seoul, South Korea, and Albuquerque, NM – August 9, 2022 – Deep Bio, a company concentrating on SaMD (Software as a Medical Device) for digital pathology, is offering clinically validated, AI-based DeepDx® algorithms, and Indica Labs, a leading provider of computational pathology software and services, are excited to announce the successful integration of the DeepDx® Prostate algorithm into the HALO AP® platform from Indica Labs.
Albuquerque, NM, 10 January, 2022 – Indica Labs, a leading provider of computational pathology software and services, is proud to announce that following ISO13485 certification, HALO AP® has received a CE Mark for use in primary diagnosis within the European Economic Area, Switzerland, and the UK.
